PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.77%
Both yoy net incomes decline, with MRVL at -996.75%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
7.42%
Some D&A expansion while MRVL is negative at -0.77%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
49.29%
Some yoy growth while MRVL is negative at -4246.88%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
55.88%
SBC growth well above MRVL's 9.56%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-227.14%
Negative yoy working capital usage while MRVL is 101.42%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-38.62%
Both yoy AR lines negative, with MRVL at -3.77%. Martin Whitman would suspect an overall sector lean approach or softer demand.
7.69%
Inventory shrinking or stable vs. MRVL's 133.63%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-670.00%
Both negative yoy AP, with MRVL at -94.43%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-261.98%
Negative yoy usage while MRVL is 19.67%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1650.00%
Negative yoy while MRVL is 1.78%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-47.14%
Both yoy CFO lines are negative, with MRVL at -40.71%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-8.71%
Both yoy lines negative, with MRVL at -83.21%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
6500.00%
Acquisition spending well above MRVL's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-89.63%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-22.87%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-566.67%
Both yoy lines negative, with MRVL at -109.09%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-970.42%
Both yoy lines negative, with MRVL at -59.97%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-57.09%
Both yoy lines negative, with MRVL at -0.46%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
44.44%
We slightly raise equity while MRVL is negative at -80.67%. John Neff sees competitor possibly preserving share count or buying back shares.
95.38%
We have some buyback growth while MRVL is negative at -175.00%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.